<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
  <channel>
    <title>DSpace Collection: 211 - 341</title>
    <link>http://localhost:8080/xmlui/handle/123456789/9028</link>
    <description>211 - 341</description>
    <pubDate>Wed, 15 Apr 2026 17:30:57 GMT</pubDate>
    <dc:date>2026-04-15T17:30:57Z</dc:date>
    <item>
      <title>When a Neisseria meningitidis PCR limitation contributes to an immunological disease diagnosis</title>
      <link>http://localhost:8080/xmlui/handle/123456789/9064</link>
      <description>Title: When a Neisseria meningitidis PCR limitation contributes to an immunological disease diagnosis</description>
      <pubDate>Mon, 01 Apr 2024 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://localhost:8080/xmlui/handle/123456789/9064</guid>
      <dc:date>2024-04-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Coexistent diffuse large B-cell lymphoma and disseminated Mycobacterium avium complex infection in a person with AIDS</title>
      <link>http://localhost:8080/xmlui/handle/123456789/9059</link>
      <description>Title: Coexistent diffuse large B-cell lymphoma and disseminated Mycobacterium avium complex infection in a person with AIDS</description>
      <pubDate>Mon, 01 Apr 2024 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://localhost:8080/xmlui/handle/123456789/9059</guid>
      <dc:date>2024-04-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>The impact of nontuberculous mycobacterial lung disease in critically ill patients: Significance for survival and ventilator use</title>
      <link>http://localhost:8080/xmlui/handle/123456789/9055</link>
      <description>Title: The impact of nontuberculous mycobacterial lung disease in critically ill patients: Significance for survival and ventilator use
Authors: Chien, Ying-Chun; Chang, Chin-Hao; Huang, Chun-Kai; dkk.
Abstract: Background: This study investigates the impact of nontuberculous mycobacterial lung disease (NTM-LD) on mortality and mechanical ventilation use in critically ill patients. Methods: We enrolled patients with NTM-LD or tuberculosis (TB) in intensive care units (ICU) and analysed their association with 30-day mortality and with mechanical ventilator-free survival (VFS) at 30 days after ICU admission. Results: A total of 5996 ICU-admitted patients were included, of which 541 (9.0 %) had TB and 173 (2.9 %) had NTM-LD. The overall 30-day mortality was 22.2 %. The patients with NTM-LD had an adjusted hazard ratio (aHR) of 1.49 (95 % CI, 1.06-2.05), and TB patients had an aHR of 2.33 (95 % CI, 1.68-3.24), compared to ICU patients with negative sputum mycobacterial culture by multivariable Cox proportional hazard (PH) regression. The aHR of age&lt;65 years, obesity, idiopathic pulmonary fibrosis, end-stage kidney disease, active cancer and autoimmune disease and diagnosis of respiratory failure were also significantly positively associated with ICU 30-day mortality. In multivariable Cox PH regression for VFS at 30 days in patients requiring invasive mechanical ventilation, NTM-LD was negatively associated with VFS (aHR 0.71, 95 % CI: 0.56e0.92, p Z 0.009), while TB showed no significant association. The diagnosis of respiratory failure itself predicted unfavourable outcome for 30-day mortality and a negative impact on VFS at 30 days. Conclusions: NTM-LD and TB were not uncommon in ICU and both were correlated with increasing 30-day mortality in ICU patients. NTM-LD was associated with a poorer outcome in terms of VFS at 30 days.</description>
      <pubDate>Mon, 01 Apr 2024 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://localhost:8080/xmlui/handle/123456789/9055</guid>
      <dc:date>2024-04-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Ribotypes and antimicrobial susceptibility profiles of clinical Clostridioides difficile isolates: A multicenter, laboratory-based surveillance in Taiwan, 2019e2021</title>
      <link>http://localhost:8080/xmlui/handle/123456789/9050</link>
      <description>Title: Ribotypes and antimicrobial susceptibility profiles of clinical Clostridioides difficile isolates: A multicenter, laboratory-based surveillance in Taiwan, 2019e2021
Authors: Tsai, Chin-Shiang; Lu, Po-Liang; Lu, Min-Chi; dkk.
Abstract: Background: The clinical burden of Clostridioides difficile infections (CDIs) remains substantial globally. This study aimed to investigate the ribotypes (RTs) and antimicrobial susceptibility of C. difficile isolates collected in Taiwan. Methods: C. difficile isolates were prospectively collected from four medical centers in Taiwan from 2019 to 2021. In a reference laboratory, in vitro susceptibility to clindamycin, moxifloxacin, metronidazole, vancomycin, fidaxomicin, and rifaximin were tested, and ribotyping was conducted to determine their genetic diversity. Results: A total of 568 C. difficile isolates were included. Metronidazole resistance was not observed, and the susceptibility rate of vancomycin was 99.5 %. Clindamycin showed poor activity against these isolates, with a resistance rate of 74.8 %. Fidaxomicin exhibited potent activity and 97.4 % of isolates were inhibited at 0.25 mg/mL. Rifaximin MIC90 increased from 0.015 mg/mL in 2019 to 0.03 mg/mL in 2020 and 2021. Of 40 RTs identified, two predominant RTs were RT 078/126 (78, 14 %) and 014/020 (76, 13 %). RT 017, traditional harboring truncated tcdA, accounted for 3 % (20 isolates) and there was no isolate belonging to RT 027. The proportions of RT 078 increased from 11.2 % in 2019 to 17.1 % in 2021, and the predominance of RT 078/126 was more evident in central Taiwan. Conclusions: Vancomycin, fidaxomicin, and metronidazole remain in vitro effective against clinical C. difficile isolates in Taiwan. The reservoirs and genetic relatedness of two major RTs with zoonotic potentials, RT 078/126 and 014/020, warrant further investigations.</description>
      <pubDate>Mon, 01 Apr 2024 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://localhost:8080/xmlui/handle/123456789/9050</guid>
      <dc:date>2024-04-01T00:00:00Z</dc:date>
    </item>
  </channel>
</rss>

